These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27009083)

  • 1. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein.
    Meili M; Kutz A; Briel M; Christ-Crain M; Bucher HC; Mueller B; Schuetz P
    BMC Pulm Med; 2016 Mar; 16():43. PubMed ID: 27009083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?
    Meili M; Müller B; Kulkarni P; Schütz P
    Expert Rev Respir Med; 2015 Oct; 9(5):587-601. PubMed ID: 26366806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.
    Holm A; Pedersen SS; Nexoe J; Obel N; Nielsen LP; Koldkjaer O; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):555-60. PubMed ID: 17727748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of treatment failure in hospitalised community acquired pneumonia.
    Menéndez R; Cavalcanti M; Reyes S; Mensa J; Martinez R; Marcos MA; Filella X; Niederman M; Torres A
    Thorax; 2008 May; 63(5):447-52. PubMed ID: 18245147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability in community-acquired pneumonia: one step forward with markers?
    Menéndez R; Martinez R; Reyes S; Mensa J; Polverino E; Filella X; Esquinas C; Martinez A; Ramirez P; Torres A
    Thorax; 2009 Nov; 64(11):987-92. PubMed ID: 19762338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
    Kutz A; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Schuetz P
    Crit Care; 2015 Mar; 19(1):74. PubMed ID: 25887979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.
    Prat C; Domínguez J; Rodrigo C; Giménez M; Azuara M; Jiménez O; Galí N; Ausina V
    Pediatr Infect Dis J; 2003 Nov; 22(11):963-8. PubMed ID: 14614368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
    Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
    Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.
    Burkhardt O; Ewig S; Haagen U; Giersdorf S; Hartmann O; Wegscheider K; Hummers-Pradier E; Welte T
    Eur Respir J; 2010 Sep; 36(3):601-7. PubMed ID: 20185423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.
    van der Starre WE; Zunder SM; Vollaard AM; van Nieuwkoop C; Stalenhoef JE; Delfos NM; Van't Wout JW; Spelt IC; Blom JW; Leyten EM; Koster T; Ablij HC; van Dissel JT
    Clin Microbiol Infect; 2014 Oct; 20(10):1048-54. PubMed ID: 25039648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
    Magrini L; Gagliano G; Travaglino F; Vetrone F; Marino R; Cardelli P; Salerno G; Di Somma S
    Clin Chem Lab Med; 2014 Oct; 52(10):1465-72. PubMed ID: 24803611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
    de Kruif MD; Limper M; Gerritsen H; Spek CA; Brandjes DP; ten Cate H; Bossuyt PM; Reitsma PH; van Gorp EC
    Crit Care Med; 2010 Feb; 38(2):457-63. PubMed ID: 20083920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.
    Patel N; Belcher J; Thorpe G; Forsyth NR; Spiteri MA
    Respir Res; 2015 May; 16(1):62. PubMed ID: 26018813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.